| Issue |
BIO Web Conf.
Volume 100, 2024
International Scientific Forum “Modern Trends in Sustainable Development of Biological Sciences” (IFBioScFU 2024)
|
|
|---|---|---|
| Article Number | 01017 | |
| Number of page(s) | 7 | |
| Section | Interdisciplinary Research in Biophysics, Biomedicine, and Neuroscience | |
| DOI | https://doi.org/10.1051/bioconf/202410001017 | |
| Published online | 08 April 2024 | |
Study on erythropoiesis-, leukopoiesis- and thrombocytopoiesis – stimulating activity of compounds BIV-241, BIV-242, BIV-243
1 Abai Kazakh National Pedagogical University, Almaty, 050010, Kazakhstan
2 Al-Farabi Kazakh National University, Almaty, 050040, Kazakhstan
3 Asfendiyarov Kazakh National Medical University, Almaty, 050000, Kazakhstan
* Corresponding author: sokolenko.anastassiya@gmail.com
The significance of the study is due to the problem of the increase in patients with secondary forms of leukopoiesis-depressive diseases. The development of leukopoiesis-stimulating drugs is necessary. These drugs are used in the treatment of cancer patients to prevent the development of febrile neutropenia, to stimulate the immune system in the postoperative period, to restore immune reactivity in environmentally caused secondary immunodeficiency syndrome. The rate of increase in patients with the secondary form of leukopoiesis-depressive syndrome is due to the increased use of cytostatic drugs. Preclinical work was carried out to study new synthetic compounds BIV-241 (dimethyl ((4-methoxyphenyl)(4-(pyrimidin-2-yl)piperazin-1-yl)methyl)phosphonate), BIV-242 (dimethyl ((3-methoxyphenyl)(4-(pyrimidin-2-yl)piperazin-1-yl)methyl)phosphonate), BIV-243 (dimethyl ((2-fluorophenyl)(4-(pyrimidin-2-yl)piperazin-1-yl)methyl)phosphonate) for leukopoiesis-stimulating activity. The studies were conducted on a cyclophosphamide-induced model of pancytopenia on outbred white rats. Compounds BIV-241 and BIV-242 did not show the desired activity. Compound BIV-243 is of interest for further development, as it had moderate leukopoiesis-, erythrocytopoiesis- and thrombocytopoiesis-stimulating activity.
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.